TrialStem cells translational medicine2023

Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring.

Li Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.